MHRA advice on amphotericin B

The MHRA has reminded healthcare professionals that the use of lipid-based and non-lipid-based formulations of amphotericin B is not interchangeable.

They have issued the following advice:

  • For Fungizone, do not exceed a total daily dose of 1.5mg/kg.
  • To prevent inadvertent overdose, verify the product name and dose before administration, especially if the dose prescribed exceeds 1.5mg/kg.

View MHRA Drug Safety Update

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more